Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Nektar announces positive results from NKTR-102 Phase 2 study on metastatic breast cancer

Nektar Therapeutics announced today that positive results from the company's Phase 2 clinical study of NKTR-102 in patients with metastatic breast cancer were presented at the ASCO 2011 Breast Cancer Symposium in San Francisco, California.

12 Sep 2011

Moffitt researchers employ LC-MRM to detect acquired multiple myeloma drug resistance

"Acquired drug resistance" (ADR) is a major problem encountered in treating some forms of cancer. The ability to monitor the proteins involved in drug resistance has been a hurdle facing cancer researchers. However, a team of researchers at Moffitt Cancer Center, and colleagues, are pioneering promising research utilizing a monitoring technology that could provide a better understanding of ADR and assist in clinical decision-making for developing individualized patient treatments for multiple myeloma.

9 Sep 2011

AstraZeneca Canada introduces new NEXIUM Patient Support program

Canadian pharmaceutical company, AstraZeneca Canada Inc., has introduced a new NEXIUM® Patient Support program designed to give physicians and pharmacists the ability to take cost out of the equation in the patient's choice between NEXIUM® tablets and a generic esomeprazole product.

9 Sep 2011

Chemotherapy before or after breast-conserving therapy does not impact treatment success

Whether chemotherapy is given before or after breast-conserving therapy (BCT) does not have an impact on long-term local-regional outcomes, suggesting treatment success is due more to biologic factors than chemotherapy timing, according to a study by researchers at The University of Texas MD Anderson Cancer Center.

9 Sep 2011

ASTRO, Cancer Support Community Greater Miami partner to raise awareness on survivorship issues

As part of an initiative to give back to the cancer communities in the cities visited during its annual scientific meetings, the American Society for Radiation Oncology (ASTRO) is partnering with the Cancer Support Community Greater Miami to raise awareness of cancer survivorship issues.

9 Sep 2011

Stage III lung cancer patients can benefit from concurrent chemo and radiation therapy

Nearly 50,000 Americans are diagnosed each year with stage III or locally advanced NSCLC, for which surgery is usually not a viable treatment option. Optimizing nonsurgical treatment strategies for these patients is an ongoing research endeavor.

9 Sep 2011

Study examines alcohol use in relation to successful ageing among women

Among 13,894 women in the Nurses' Health Study, investigators prospectively examined alcohol use assessed at midlife in relation to "successful ageing," which was defined as survival to age 70 years, not having a major chronic disease, and having no major cognitive impairment, physical impairment, or mental health problems.

9 Sep 2011

Cardiovascular and Renal Drugs Advisory Committee recommends FDA approval of J&JPRD's rivaroxaban

Johnson & Johnson Pharmaceutical Research and Development, L.L.C. (J&JPRD) announced today that the U.S. Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee recommended approval of rivaroxaban, a novel, once-daily, oral anticoagulant, for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation.

9 Sep 2011

Pancreatic cancer outcomes poor in UK – experts urge better diagnosis and treatment

A new report reveals that survival rates in the UK for people with pancreatic cancer are among the worst in the world. The report recommends earlier diagnosis and better treatment.

8 Sep 2011

World Cancer Research Fund urges action to stop preventable cancers

According to the WCRF this Wednesday healthier lifestyles and better diets could prevent up to 2.8 million cases of cancer each year. The WCRF called upon governments to “avoid a public health disaster”.

8 Sep 2011

Breast-conservation therapy and mastectomy provide similar survival rates for early-stage breast cancer

Young women with early-stage breast cancer have similar survival rates with a lumpectomy and radiation treatment, known as breast-conservation therapy, as with mastectomy, a new study conducted at the University of Maryland has found. The results of the analysis of nearly 15,000 patients listed in a nationwide cancer registry will be presented at the 2011 Breast Cancer Symposium to be held Sept. 8-11 in San Francisco.

8 Sep 2011

New studies on breast cancer screening, treatment and survival

New studies on breast cancer screening, treatment, and survival were released today in advance of the 2011 Breast Cancer Symposium. The symposium is being held September 8-10, 2011, at the San Francisco Marriott Marquis in San Francisco.

8 Sep 2011

Pulitzer photojournalist with lymphoma films his experiences

Diagnosed at age 48 with a potentially deadly form of lymphoma, Pulitzer Prize-winning photojournalist John Kaplan turned the lens on himself and chronicled his experience in a moving visual journal. Kaplan's new film, Not As I Pictured, is now showing on PBS stations nationwide.

8 Sep 2011

Exercise, intervention may help individuals with peripheral arterial disease

Peripheral arterial disease, or PAD, is a common condition affecting 12-20 percent of Americans age 65 and older that may be a signal of future heart attack and stroke-and many with the disease may be unaware they have it, says the Society of Interventional Radiology.

8 Sep 2011

Ohio Third Frontier grants to advance Philips Healthcare Global Advanced Imaging Innovation Center

The Ohio Third Frontier Commission has awarded $2.5 million in research grants to advance the Philips Healthcare Global Advanced Imaging Innovation Center, a collaboration among Case Western Reserve University, University Hospitals (UH) Case Medical Center and Philips Healthcare. The research projects are part of $30 million in funding awarded throughout the State of Ohio this week by the Ohio Third Frontier Commission.

8 Sep 2011

Physical, sexual abuse and threats prevent adolescent girls from having their partner use condoms

Partner abuse leads to HIV infection, and black women are most at risk. A new study at the University of Pennsylvania School of Nursing has found that 46 percent of African-American adolescent girls report that their partner did not use a condom the last time they had sex -- often because of partner abuse. The girls described physical and sexual abuse and threats as preventing them from having their partner use condoms.

7 Sep 2011

BioLineRx, Tel Aviv University sign license agreement to develop and commercialize BL-7050

BioLineRx, a biopharmaceutical development company, today announced that it has signed a worldwide, exclusive license agreement with Ramot at Tel Aviv University Ltd., the technology transfer company of Tel Aviv University, for the development and commercialization of BL-7050, a novel, orally-available treatment for neuropathic and inflammatory pain.

7 Sep 2011

ImmunoCellular provides update on ICT-107 Phase II trial for glioblastoma multiforme

ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, provided an update today on clinical trial site activity and patient enrollment for its Phase II clinical trial of ICT-107, the Company's dendritic cell based cancer vaccine candidate targeting multiple tumor antigens for the treatment of glioblastoma multiforme.

7 Sep 2011

Glioma stem cells can change their metabolic state at will, finds study

The metabolic state of glioma stem cells, which give rise to deadly glioblastomas, is significantly different from that of the brain cancer cells to which they give birth, a factor which helps those stem cells avoid treatment and cause recurrence later.

7 Sep 2011

Combination of blood tests and ROMA algorithm receives FDA clearance to treat ovarian cancer

Approval last week by U.S. Food and Drug Administration (FDA) clears the path for nationwide use of tools that show the greatest specificity in estimating the risk of ovarian cancer in women with a pelvic mass.

7 Sep 2011

Oncology News and Research

Further Reading

Nektar announces positive results from NKTR-102 Phase 2 study on metastatic breast cancer

Moffitt researchers employ LC-MRM to detect acquired multiple myeloma drug resistance

AstraZeneca Canada introduces new NEXIUM Patient Support program

Chemotherapy before or after breast-conserving therapy does not impact treatment success

ASTRO, Cancer Support Community Greater Miami partner to raise awareness on survivorship issues

Stage III lung cancer patients can benefit from concurrent chemo and radiation therapy

Study examines alcohol use in relation to successful ageing among women

Cardiovascular and Renal Drugs Advisory Committee recommends FDA approval of J&JPRD's rivaroxaban

Pancreatic cancer outcomes poor in UK – experts urge better diagnosis and treatment

World Cancer Research Fund urges action to stop preventable cancers

Breast-conservation therapy and mastectomy provide similar survival rates for early-stage breast cancer

New studies on breast cancer screening, treatment and survival

Pulitzer photojournalist with lymphoma films his experiences

Exercise, intervention may help individuals with peripheral arterial disease

Ohio Third Frontier grants to advance Philips Healthcare Global Advanced Imaging Innovation Center

Physical, sexual abuse and threats prevent adolescent girls from having their partner use condoms

BioLineRx, Tel Aviv University sign license agreement to develop and commercialize BL-7050

ImmunoCellular provides update on ICT-107 Phase II trial for glioblastoma multiforme

Glioma stem cells can change their metabolic state at will, finds study

Combination of blood tests and ROMA algorithm receives FDA clearance to treat ovarian cancer

A best-practice guide for laboratory services in oncology trials eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News